Bb5a31f81ClaimTraditional drug development relies on empirical trial-and-error screening processes rather than predictive computational modelingAgreeDisagree
Bb5a31f81ClaimIsomorphic Labs trains computational models to predict molecular structures and interactions at experimental accuracyAgreeDisagree
Bb5a31f81ClaimIsomorphic Labs partners with biopharmaceutical companies to apply its artificial intelligence drug design engine to partner drug targetsAgreeDisagree
Bb5a31f81ClaimAlphaFold's demonstration of protein structure prediction served as the proof of concept that led to the founding of Isomorphic LabsAgreeDisagree
Bb5a31f81ClaimAs of November 2026, the average development cost of a new drug has risen to approximately 1.5 billion dollarsAgreeDisagree
Bb5a31f81ClaimPreclinical toxicity studies conducted in rats are approximately 30 percent predictive of clinical toxicity in humansAgreeDisagree
Bb5a31f81ClaimMost candidate drugs fail during human clinical trials rather than during preclinical in-vitro researchAgreeDisagree
Bb5a31f81ClaimIsomorphic Labs utilizes automated laboratories to generate experimental data to power computational modelsAgreeDisagree
Bb5a31f81ClaimIsomorphic Labs internally prioritizes drug discovery programs targeting oncology, immunology, and inflammationAgreeDisagree
Bb5a31f81ClaimDeveloping a new drug traditionally takes approximately 15 years from initial discovery to regulatory approvalAgreeDisagree
Bb5a31f81ClaimAutomated wet laboratories and robotic platforms remain constrained by physical reaction rates and cell culturing timesAgreeDisagree
Bb5a31f81ClaimTraditional pharmaceutical research typically treats each drug program as a bespoke project, limiting transferable learnings to subsequent programsAgreeDisagree
Bb5a31f81ClaimDetermining protein structures through X-ray crystallography traditionally requires months or years of laboratory experimentsAgreeDisagree
Bb5a31f81ClaimDespite an expansion in biomedical literature and drug modalities, the annual number of new drug approvals has remained roughly flatAgreeDisagree
Bb5a31f81ClaimThe RAS protein family has been studied as a driver of cancer in biological research since the early 1990sAgreeDisagree
Bb5a31f81ClaimPrecise molecular engineering aims to eliminate off-target liver toxicity to permit the simultaneous administration of multidrug cocktailsAgreeDisagree
Bb5a31f81ClaimIsomorphic Labs maintains an internal proprietary drug discovery pipeline that Isomorphic Labs fully owns and fundsAgreeDisagree
Bb5a31f81ClaimIsomorphic Labs relies on physical laboratory experiments primarily for hypothesis validation rather than iterative discoveryAgreeDisagree
Bb5a31f81ClaimAlphaGenome increased genomic prediction resolution from Enformer's 128 base pairs down to single base-pair resolutionAgreeDisagree
Bb5a31f81ClaimResearchers at the Francis Crick Institute experimentally validated that a non-coding variant regulates a target gene situated 290,000 base pairs awayAgreeDisagree